021-51111890
购物车（）
sales@molnova.cn
MARK4 inhibitor 1
CAS No. 2271081-58-2
MARK4 inhibitor 1 ( —— )
产品货号. M24033 CAS No. 2271081-58-2
MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2203 | 有现货 |
|
| 10MG | ￥3208 | 有现货 |
|
| 25MG | ￥5387 | 有现货 |
|
| 50MG | ￥7671 | 有现货 |
|
| 100MG | ￥10368 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MARK4 inhibitor 1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?
-
产品描述MARK4 inhibitor 1 inhibits cancer cell proliferation, metastasis and induces apoptosis.?MARK4 inhibitor 1 is a potent microtubule affinity-regulating kinase 4 (MARK4) inhibitor, with an IC50 of 1.54 μM.?
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体MARK4
-
研究领域——
-
适应症——
化学信息
-
CAS Number2271081-58-2
-
分子量390.4
-
分子式C20H18N6O3
-
纯度>98% (HPLC)
-
溶解度DMSO:10 mM
-
SMILESO=C(C1=CN(CC2=CC=C(OC)C=C2)N=N1)N\N=C3C4=CC=CC(C)=C4NC\3=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Aneja B, et al. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis. Eur J Med Chem. 2019 Feb 1;163:840-852.
产品手册
关联产品
-
Bufotenine
Bufotenine may have hallucinogenic potential, the presence and levels of bufotenine might be useful and important markers of some psychiatric disorders. Bufotenine is able to block rabies virus infection in BHK-21 cells.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Lenacapavir
Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
